PO.TB05.01 · 肿瘤生物学
CyTOF分析尤因肉瘤细胞系在体外和体内的异质性
CyTOF analysis of heterogeneity between Ewing sarcoma cell lines in vitro and in vivo
作者与单位 Authors & Affiliations
摘要 Abstract
中文摘要
引言:尤因肉瘤(ES)是儿童第二常见的骨肿瘤,已知由一种致癌性融合基因驱动,最常见的是EWS:FLI1。近期研究发现ES肿瘤具有异质性,肿瘤内存在EWS:FLI1融合水平各异的细胞群体。这些群体在形态、增殖、药物敏感性和侵袭性方面存在差异。此外,已知ES肿瘤内也存在肿瘤干细胞群体,这些细胞在形态和药物敏感性方面同样存在差异。本研究的目的是使用CyTOF评估各种ES细胞系在体外和体内的EWS:FLI1融合和肿瘤干细胞异质性以及免疫浸润的差异。
方法:在体外,将A673、TC71、RDES和SL00015细胞分别以相等数量接种,并于次日染色进行CyTOF分析。在体内,将A673、RDES或SL00015细胞皮下注射到裸鼠体内。一旦肿瘤达到1500-2000mm³,即将其取出并解离进行CyTOF分析。所用的CyTOF检测组合设计用于评估EWS:FLI1融合异质性、肿瘤干细胞群体和免疫细胞浸润。使用OMIQ进行数据分析,包括采用UMAP可视化的phenograph聚类、表达模式热图以及肿瘤和免疫细胞群体的变化。
结果:在体外,这4种细胞系各具不同的形态,其生长方式从贴壁到悬浮的细胞簇不等。Phenograph聚类揭示了各细胞系之间不同的表达模式。有趣的是,不同细胞系在体内生长时的表达模式相互聚类的程度,高于体内生长细胞与其体外对应物之间的聚类程度。总体而言,与体外生长的相应细胞系相比,体内生长的细胞具有更高比例的EWS:FLI1低表达群体。肿瘤干细胞的数量在各细胞系和样本类型之间各不相同,尽管其比例通常在体外样本中高于体内。此外,免疫浸润在由不同细胞系形成的肿瘤中也各不相同,其中RDES肿瘤的总体浸润最多。
结论:本研究所用的CyTOF检测组合能够识别各细胞系和样本类型之间不同的表达模式。在细胞系体外或体内生长之间所识别出的表达模式差异,在尤因肉瘤背景下的药物疗效或机制研究中可能是一项重要的考量因素。
查看英文原文 English abstract
Introduction : Ewing sarcoma (ES) is the second most common bone cancer in children and is known to be driven by an oncogenic fusion, most commonly EWS:FLI1. Recent work has identified that ES tumors are heterogenous and there are populations of cells within tumors with varying levels of the EWS:FLI1 fusion. These populations have differences in morphology, proliferation, drug sensitivities, and invasiveness. Further, it is known that cancer stem cell populations are also found within ES tumors and these cells also have differences in morphology and drug sensitivity. The purpose of this study was to use CyTOF to assess differences in EWS:FLI1 fusion and cancer stem cell heterogeneity and immune infiltration between various ES cell lines in vitro and in vivo.
Methods : In vitro, A673, TC71, RDES, and SL00015 cells were seeded separately at equal numbers and stained for CyTOF the following day. In vivo, A673, RDES, or SL00015 cells were injected subcutaneously into Nude mice. Once tumors reached 1500-2000mm 3 , they were harvested and dissociated for CyTOF analysis. The CyTOF panel used was designed to assess EWS:FLI1 fusion heterogeneity, the cancer stem cell population, and immune cell infiltration. OMIQ was used for data analysis which included phenograph clustering with UMAP visualization, heatmap of expression patterns, and changes in tumor and immune cell populations.
Results : In vitro, each of the 4 cell lines have varying morphologies and their growth ranges from adherent to clusters of cells in suspension. Phenograph clustering revealed different expression patterns among the cell lines. Interestingly, the expression patterns of different cell lines grown in vivo clustered together more than the in vivo grown cells did with their in vitro counterpart. Overall, the cells grown in vivo had a higher percentage of the EWS:FLI1 low population compared to the respective cell line grown in vitro. The amount of cancer stem cells varied among cell lines and sample types, though the percentage was generally higher in the in vitro samples compared to in vivo. Further, immune infiltration also varied across tumors formed from different cell lines with the RDES tumors having the most overall infiltration.
Conclusions : The CyTOF panel used in this study can identify distinct expression patterns among cell lines and sample types. The differences in expression patterns identified between a cell line grown in vitro or in vivo could be an important consideration in drug efficacy or mechanism studies in the context of Ewing sarcoma.
利益披露 Disclosure
P. Harrell, None..
L. Golzar, None..
K. Wells, None..
P. Gourabathini, None..
K. Q. McKinney, None..
E. M. Trovillion, None..
J. Oesterheld, None..
K. H. Smith, None.